{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:23:18Z","timestamp":1772817798630,"version":"3.50.1"},"reference-count":24,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,9,1]]},"abstract":"<jats:p>Objective. In 2000, heptavalent pneumococcal conjugate vaccine (PCV7) was recommended for children younger than 2 years, but its high cost relative to other universally recommended childhood immunizations and variability in insurance coverage for the vaccine raised concerns. We investigated the influence of PCV7 cost and insurance coverage on physician recommendation of PCV7 to their patients and administration of PCV7 in their practices.<\/jats:p><jats:p>Methods. We conducted a mail survey from April to July 2001 of a random sample of 833 pediatricians and 788 family physicians in 24 states with different vaccine financing strategies (Vaccines for Children [VFC]-only; enhanced VFC; universal purchase). Physicians specified the proportion of children in their practice with insurance coverage for PCV7, where they recommend administering PCV7, and whether they have concerns about the cost of PCV7.<\/jats:p><jats:p>Results. The response rate was 60%. Overall, 87% of physicians recommend PCV7 for children younger than 2 years (99% pediatricians; 68% family physicians). Among physicians who recommend PCV7, 98% said that they would administer the vaccine in their own practices for children whose insurance covers the vaccine. However, only 56% of physicians who recommend PCV7 reported that all children in their practices had insurance coverage for the vaccine, whereas 24% of physicians reported 86% to 99% of children with coverage and 20% reported \u226485% of children with coverage. Among physicians in the last group with the lowest PCV7 insurance coverage rates in their practices, only 44% said that they would administer the vaccine in their own practices to children without PCV7 coverage, compared with 62% of physicians who provide care to children with higher rates of PCV7 coverage. Physicians in states with VFC-only vaccine financing strategies for PCV7 are less likely to administer PCV7 in their own practices to children without coverage than physicians in states with enhanced VFC and universal purchase strategies (48% vs 64% vs 74%). Almost one third of physicians who recommend PCV7 are concerned about the cost of PCV7; those with cost concerns are more likely to recommend that children without insurance coverage for PCV7 receive the vaccine at a public health clinic rather than in their own practices (45% vs 29%). Physicians with cost concerns are also more likely to say that they now screen children for insurance coverage more than for previously recommended vaccines (52% vs 21% for physicians without cost concerns).<\/jats:p><jats:p>Conclusions. Nationwide, physician adoption of PCV7 recommendations is high, but where physicians recommend that PCV7 be administered differs significantly by children\u2019s variable insurance coverage for the vaccine and by state vaccine financing strategies. Physicians\u2019 concerns about the cost of PCV7 may foreshadow their responses to future children\u2019s vaccines that may be even more expensive.<\/jats:p>","DOI":"10.1542\/peds.112.3.521","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:43:47Z","timestamp":1092444227000},"page":"521-526","source":"Crossref","is-referenced-by-count":46,"title":["Influence of Insurance Status and Vaccine Cost on Physicians\u2019 Administration of Pneumococcal Conjugate Vaccine"],"prefix":"10.1542","volume":"112","author":[{"given":"Matthew M.","family":"Davis","sequence":"first","affiliation":[{"name":"Child Health Evaluation and Research (CHEAR) Unit, Division of General Pediatrics, University of Michigan, Ann Arbor, Michigan"},{"name":"Division of General Internal Medicine, University of Michigan, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serigne M.","family":"Ndiaye","sequence":"additional","affiliation":[{"name":"National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary L.","family":"Freed","sequence":"additional","affiliation":[{"name":"Child Health Evaluation and Research (CHEAR) Unit, Division of General Pediatrics, University of Michigan, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher S.","family":"Kim","sequence":"additional","affiliation":[{"name":"Child Health Evaluation and Research (CHEAR) Unit, Division of General Pediatrics, University of Michigan, Ann Arbor, Michigan"},{"name":"Division of General Internal Medicine, University of Michigan, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah J.","family":"Clark","sequence":"additional","affiliation":[{"name":"Child Health Evaluation and Research (CHEAR) Unit, Division of General Pediatrics, University of Michigan, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2003,9,1]]},"reference":[{"key":"2021120820234987800_R1","doi-asserted-by":"crossref","unstructured":"Davis MM, Zimmerman JL, Wheeler JRC, Freed GL. Public-sector childhood vaccine costs: past trends, future expectations. Am J Public Health.2002;92:1982\u20131987","DOI":"10.2105\/AJPH.92.12.1982"},{"key":"2021120820234987800_R2","unstructured":"Centers for Disease Control and Prevention. Vaccines for Children vaccine price list. Available at: http:\/\/www.cdc.gov\/nip\/vfc\/cdc_vac_price_list.htm. Accessed January 30, 2003"},{"key":"2021120820234987800_R3","doi-asserted-by":"crossref","unstructured":"Orenstein WA, Atkinson W, Mason D, Bernier RH. Barriers to vaccinating preschool children. J Health Care Poor Underserved.1990;1:315\u2013330","DOI":"10.1353\/hpu.2010.0324"},{"key":"2021120820234987800_R4","doi-asserted-by":"crossref","unstructured":"Hinman AR. What will it take to fully protect all American children with vaccines?Am J Dis Child.1991;145:559\u2013562","DOI":"10.1001\/archpedi.1991.02160050085023"},{"key":"2021120820234987800_R5","unstructured":"Lieu TA, Smith MD, Newacheck PW, Langhorn D, Venkatesh P, Herradora R. Health insurance and preventive care sources of children at public immunization clinics. Pediatrics.1994;93:373\u2013378"},{"key":"2021120820234987800_R6","doi-asserted-by":"crossref","unstructured":"Santoli J, Szilagyi PG, Rodewald LE. Barriers to childhood immunizations. Pediatr Ann.1998;27:366\u2013374","DOI":"10.3928\/0090-4481-19980601-11"},{"key":"2021120820234987800_R7","unstructured":"Institute of Medicine. Calling the Shots: Immunization Finance Policies and Practices. Washington, DC: National Academy Press; 2000"},{"key":"2021120820234987800_R8","doi-asserted-by":"crossref","unstructured":"Ruch-Ross HS, O\u2019Connor KG. Immunization referral practices of pediatricians in the United States. Pediatrics.1994;94:508\u2013513","DOI":"10.1542\/peds.94.4.508"},{"key":"2021120820234987800_R9","doi-asserted-by":"crossref","unstructured":"National Vaccine Advisory Committee. The measles epidemic: the problems, barriers, and recommendations. JAMA.1991;266:1547\u20131552","DOI":"10.1001\/jama.266.11.1547"},{"key":"2021120820234987800_R10","doi-asserted-by":"crossref","unstructured":"Fairbrother G, Friedman S, Hanson KL, Butts GC. Effect of the Vaccines for Children program on inner-city neighborhood physicians. Arch Pediatr Adolesc Med.1997;151:1229\u20131235","DOI":"10.1001\/archpedi.1997.02170490055010"},{"key":"2021120820234987800_R11","doi-asserted-by":"crossref","unstructured":"Szilagyi PG, Humiston SG, Shone LP, Kolasa MS, Rodewald LE. Decline in physician referrals to health department clinics for immunizations: the role of vaccine financing. Am J Prev Med.2000;18:318\u2013324","DOI":"10.1016\/S0749-3797(00)00120-3"},{"key":"2021120820234987800_R12","doi-asserted-by":"crossref","unstructured":"Zimmerman RK, Mieczkowski TA, Mainzer HM, et al. Effect of the Vaccines for Children program on physician referral of children to public vaccine clinics: a pre-post comparison. Pediatrics.2001;108:297\u2013304","DOI":"10.1542\/peds.108.2.297"},{"key":"2021120820234987800_R13","doi-asserted-by":"crossref","unstructured":"Szilagyi PG, Humiston SG, Shone LP, Kolasa MS, Rodewald LE. Impact of vaccine financing on vaccinations delivered by health department clinics. Am J Public Health.2000;90:739\u2013745","DOI":"10.2105\/AJPH.90.5.739"},{"key":"2021120820234987800_R14","doi-asserted-by":"crossref","unstructured":"Davis MM, Andreae M, Freed GL. Physicians\u2019 early responses to pneumococcal conjugate vaccine. Ambul Pediatr.2001;1:302\u2013305","DOI":"10.1367\/1539-4409(2001)001<0302:PECRTT>2.0.CO;2"},{"key":"2021120820234987800_R15","doi-asserted-by":"crossref","unstructured":"Lieu TA, Finkelstein JA, Adams MM, et al. Pediatricians\u2019 views on financial barriers and values for pneumococcal vaccine for children. Ambul Pediatr.2002;2:358\u2013366","DOI":"10.1367\/1539-4409(2002)002<0358:PVOFBA>2.0.CO;2"},{"key":"2021120820234987800_R16","doi-asserted-by":"crossref","unstructured":"Schaffer SJ, Szilagyi PG, Shone LP, et al. Physician perspectives regarding pneumococcal conjugate vaccine. Pediatrics.2002;110(6). Available at: http:\/\/www.pediatrics.org\/cgi\/content\/full\/110\/6\/e68","DOI":"10.1542\/peds.110.6.e68"},{"key":"2021120820234987800_R17","unstructured":"American Academy of Pediatrics. AAP recommends pneumococcal vaccine for children under age 2. Press release. June 6, 2000. Available at: http:\/\/www.aap.org\/advocacy\/archives\/junpcv7.htm. Accessed January 30, 2003"},{"key":"2021120820234987800_R18","unstructured":"American Academy of Family Physicians. Recommendation for pneumococcal conjugate immunization. Available at: http:\/\/www.aafp.org\/x1556.xml. Accessed January 30, 2003"},{"key":"2021120820234987800_R19","unstructured":"Centers for Disease Control and Prevention. ACIP vote regarding pneumococcal conjugate vaccine. Press release. June 26, 2000. Available at: http:\/\/www.cdc.gov\/od\/oc\/media\/pressrel\/r2k0626.htm. Accessed January 30, 2003"},{"key":"2021120820234987800_R20","doi-asserted-by":"crossref","unstructured":"Davis MM, Ndiaye SM, Freed GL, Clark SJ. One-year uptake of pneumococcal conjugate vaccine: a national survey of family physicians and pediatricians. J Am Board Fam Pract. 2003. In press","DOI":"10.3122\/jabfm.16.5.363"},{"key":"2021120820234987800_R21","unstructured":"Centers for Disease Control and Prevention. Recommended childhood immunization schedule\u2013United States, 2001. MMWR Morb Mortal Wkly Rep.2001;50:7\u20139, 19"},{"key":"2021120820234987800_R22","doi-asserted-by":"crossref","unstructured":"Santoli JM, Rodewald LE, Maes EF, Battaglia MP, Coronado VG. Vaccines for Children program, United States, 1997. Pediatrics.1999;104(2). Available at: http:\/\/www.pediatrics.org\/cgi\/content\/full\/104\/2\/e15","DOI":"10.1542\/peds.104.2.e15"},{"key":"2021120820234987800_R23","doi-asserted-by":"crossref","unstructured":"Asch DA, Jedrziewski K, Christakis NA. Response rates to mailed surveys published in medical journals. J Clin Epidemiol.1997;50:1129\u20131136","DOI":"10.1016\/S0895-4356(97)00126-1"},{"key":"2021120820234987800_R24","unstructured":"Cummings SM, Savitz LA, Konrad TR. Reported response rates to mailed physician questionnaires. Health Serv Res.2001;35:1347\u20131355"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/112\/3\/521\/1006811\/pe0903000521.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/112\/3\/521\/1006811\/pe0903000521.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:37:11Z","timestamp":1682746631000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/112\/3\/521\/28647\/Influence-of-Insurance-Status-and-Vaccine-Cost-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,1]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2003,9,1]]},"published-print":{"date-parts":[[2003,9,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.112.3.521","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9,1]]}}}